Back    Zoom +    Zoom -
JD Maiyao Makes All Efforts to Ensure Stable Supply of Original Drugs, Overseas Healthcare Products without Price Hikes
Recommend
8
Positive
10
Negative
1
JD-SW (09618.HK) (JD.US)'s JD Maiyao (literal translation of "京東買藥") platform doubled its sales of a number of categories, including original drugs and overseas healthcare products, recently.

In response to some consumers' concerns about prices, the person in charge of JD Maiyao said that, relying on a supply chain network covering 30 GSP medicine warehouses across China and with more than 90% of orders arriving the next day, JD Maiyao made every effort to ensure a stable supply of original drugs and overseas healthcare products, without raising prices, according to The Paper.

Related NewsCCBI Chops JD-SW's TP to $213, Rating Kept Outperform

AAStocks Financial News